ABCG2 and cancer: Moreover, ABCG2 is a potential target causing the multidrug resistance in NSCLC; suppression of ABCG2 transcription, as shown in A549 cell-based models [43, 44], may reverse the multidrug resistance and thus enhance the effectiveness of other anti-cancer drugs.